Article
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2017
Ritthipichai Krit, Haymaker Cara L, Martinez Melisa, Aschenbrenner Andrew, Yi Xiaohui, Zhang Minying, Kale Charuta, Vence Luis M, Roszik Jason, Hailemichael Yared, Overwijk Willem W, Varadarajan Navin, Nurieva Roza, Radvanyi Laszlo G, Hwu Patrick, Bernatchez Chantale
Abstract excerpt
Purpose: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40%-50% in metastatic melanoma patients. BTLA (B-and-T lymphocyte associated) expression on transferred CD8+ TILs was associated with better clinical outcome. The suppressive function of the ITIM and ITSM motifs of BTLA is well described. Here, we sought to determine the functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
